Boston Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $354K | Sell |
|
|||||
|
2023
Q1 | $554K | Sell |
|
|||||
|
2022
Q4 | $786K | Sell |
|
|||||
|
2022
Q3 | $1.65M | Sell |
|
|||||
|
2022
Q2 | $2.96M | Sell |
|
|||||
|
2022
Q1 | $7.9M | Buy |
|
|||||
|
2021
Q4 | $9.3M | Buy |
|
|||||
|
2021
Q3 | $9.24M | Buy |
|
|||||
|
2021
Q2 | $9.67M | Buy |
|
|||||
|
2021
Q1 | $8.51M | Buy |
|
|||||
|
2020
Q4 | $8.7M | Sell |
|
|||||
|
2020
Q3 | $6.99M | Sell |
|
|||||
|
2020
Q2 | $7.06M | Buy |
|
|||||
|
2020
Q1 | $4.64M | Buy |
|
|||||
|
2019
Q4 | $5.7M | Sell |
|
|||||
|
2019
Q3 | $4.75M | Sell |
|
|||||
|
2019
Q2 | $5.57M | Sell |
|
|||||
|
2019
Q1 | $5.87M | Buy |
|
|||||
|
2018
Q4 | $2.35M | Sell |
|
|||||
|
2018
Q3 | $3.45M | Buy |
|
|||||
|
2018
Q2 | $3.06M | Buy |
|